American Cancer Society Adds Blood Test to Colorectal Screening Options
Lead For the first time the American Cancer Society (ACS) has added a blood-based test to its recommended options for colorectal cancer screening, announcing the change on Wednesday. The test, Guardant Health’s Shield, received FDA clearance in 2024 and is recommended only for people who cannot or will not undergo colonoscopy or stool-based tests. ACS … Read more